CASMI

Collaborations and Interfaces

Academia, industry, patient groups, regulators, and the NHS/other healthcare systems all have important parts to play in the development of new treatments, be they drugs, devices or other new therapies.

CASMI_graphic_3

CASMI’s work explores the interfaces between these organisations, from the cultures and incentives inherent within them to the clusters and collaborations that form between them.